Order Revanesse® Shape™ w/ Lidocaine for Clinics
$259.00
You save (%)
Description
Revanesse® Shape™ w/ Lidocaine is a sterile hyaluronic acid dermal filler supplied for professional facial contouring and volumizing protocols. Licensed clinics and healthcare professionals can order the 1.2 mL prefilled syringe format, supplied as two syringes per box for treatment-room planning and inventory control. The integrated lidocaine supports injection comfort during administration by trained injectors.
This clear HA gel is used in aesthetic workflows where structure, projection, and controlled placement matter. Med Wholesale Supplies serves licensed clinics, med spas, and healthcare organizations with authentic brand-name medical products sourced through vetted distributors and verified supply channels.
Revanesse® Shape™ with Lidocaine 1.2 mL: Price and Clinic Ordering
Sign in to view current Revanesse Shape price details for your clinic account. Public pricing is not displayed because access is limited to verified professional buyers, and account-level terms may vary by order volume or contract status.
Each box contains two sterile, single-use syringes, each prefilled with 1.2 mL of gel. This pack size can support bilateral contouring appointments, staged treatment plans, or replenishment for clinics that maintain separate inventory levels by filler type. During intake, your team should record the product name, lot number, expiry date, carton condition, and receiving location according to internal documentation procedures.
Clinics can align order timing with scheduled injectable sessions and site-level inventory targets. For broader brand browsing, the Revanesse product family can help teams evaluate other HA presentations used in aesthetic practice.
What This HA Filler Is Designed to Do
Revanesse® Shape™ w/ Lidocaine is an injectable hyaluronic acid gel intended for soft-tissue augmentation by qualified professionals. Hyaluronic acid is a water-binding molecule used in dermal fillers to add volume, support contour, and refine facial proportions when placed with appropriate technique.
Clinics typically choose a structural HA filler when treatment plans prioritize shape, lift, or definition rather than superficial blending alone. In professional aesthetic protocols, this may include contour-focused mapping for areas such as the midface, chin, and jawline, subject to the injector’s training, anatomy assessment, and local protocol.
The lidocaine component is included to improve injection tolerability. It does not replace careful patient assessment, aseptic technique, or complication preparedness. Staff should use the manufacturer’s package insert and clinic SOPs for handling, injection depth, needle or cannula selection, and post-procedure instructions.
How Revanesse® Shape™ Works in Professional Use
As a cohesive HA gel, this filler supports immediate three-dimensional shaping after placement. The prefilled syringe format helps streamline room setup, and the gel is designed for controlled extrusion during professional injection techniques such as bolus placement or linear threading when appropriate to the treatment plan.
Rheology, or the way a gel flows and resists deformation, is one factor clinics consider when choosing among dermal fillers. A firmer, more structural HA product may be selected for projection and support, while a softer or more flexible product may be selected for blending, fine refinement, or areas that need different movement characteristics.
For additional context on feature-focused aesthetic planning, see our article on Revanesse filler precision. Clinical teams can use educational content to support internal product discussions, but final product selection should remain tied to injector judgment and patient-specific anatomy.
Key Features for Clinic Workflow
- Clear, sterile hyaluronic acid gel for professional soft-tissue augmentation.
- Integrated lidocaine to support injection comfort during treatment.
- Two 1.2 mL prefilled syringes per box for procedure planning.
- Single-use syringe presentation to support sterile handling.
- Lot and expiry labeling for intake records and rotation.
- Format suited to contour-focused aesthetic protocols.
- Professional-use supply pathway for licensed clinics and healthcare teams.
Quick tip: Keep receiving records aligned with appointment schedules so filler inventory remains traceable from delivery through treatment-room use.
Composition, Concentration, and Presentation
The supplied presentation contains hyaluronic acid at 25 mg/mL with lidocaine at 0.3%. It is provided as a sterile, isotonic gel in prefilled syringes and is intended for single-use administration by licensed healthcare professionals trained in injectable procedures.
| Attribute | Clinic detail |
|---|---|
| Product | Revanesse® Shape™ w/ Lidocaine |
| Active component | Hyaluronic acid 25 mg/mL |
| Anesthetic | Lidocaine 0.3% |
| Format | Prefilled syringe |
| Quantity | 2 x 1.2 mL syringes per box |
| Use setting | Professional aesthetic administration |
Always use the current carton, unit label, and manufacturer materials as the controlling reference for product-specific handling, storage, and administration instructions. Do not use a syringe if sterile packaging is compromised, the product appears abnormal, or required clinic documentation cannot be completed.
Storage, Handling, and Receiving Checks
Receiving staff should inspect cartons before placing the product into clinic inventory. Confirm that seals are intact, labels are legible, and the lot and expiry details match purchasing records. Syringes should remain in their original packaging until prepared for use under clinic procedures.
Storage must follow the current manufacturer recommendations printed on the carton or insert. Keep dermal fillers away from unauthorized access, and separate expired, damaged, or quarantined units from active clinical stock. Temperature-controlled handling when required and tracked US delivery can support clean receiving workflows for multi-room or multi-site practices.
Inventory managers may pair dermal filler stocking with procedure volume, injector schedules, and seasonal treatment demand. For adjunct tools and clinic supplies, the medical devices category may help teams coordinate compatible workflow items used around injectable appointments.
Expected Responses, Warnings, and Professional Precautions
Common transient responses after HA filler injection can include swelling, redness, bruising, tenderness, firmness, itching, or localized discomfort. These effects are typically discussed during informed consent and documented according to clinic policy. Serious filler complications are uncommon but may include infection, vascular compromise, tissue injury, nodules, hypersensitivity reactions, or visual symptoms requiring urgent evaluation.
Qualified injectors should assess treatment suitability before administration. Relevant considerations include facial anatomy, prior filler history, active skin inflammation or infection, allergy history, bleeding risk, immune status, planned procedures, and any factors addressed in the product’s official instructions. Clinics should maintain protocols for adverse-event recognition, escalation, and emergency response.
Do not treat this product as interchangeable with every HA filler solely because it contains hyaluronic acid. Technique, placement depth, tissue plane, injection volume, and product selection should be determined by trained professionals. The FDA’s dermal filler safety information is a useful external reference for general risks and patient counseling responsibilities.
How It Compares With Other Revanesse Options
Clinics often build HA filler menus by matching product handling to the treatment objective. Revanesse® Shape™ w/ Lidocaine fits contour-driven work where projection and structural support are priorities. Other presentations in the Revanesse line may be used for different areas, tissue depths, or refinement goals.
For a related contour-oriented option, review Revanesse Contour with Lidocaine. Clinics evaluating texture, placement style, or protocol tiering may also consider Revanesse Ultra with Lidocaine or Revanesse Revise with Lidocaine as part of a structured HA toolkit.
Brand-to-brand comparisons should focus on clinical handling, labeled use, injector experience, and patient-specific anatomy rather than broad superiority claims. Our article on Revanesse versus Juvederm outlines practical selection factors without replacing professional training or product labeling.
Clinic Planning and Treatment-Room Fit
The two-syringe box can simplify planning for appointments that require more than one syringe available in the treatment room. It may also reduce mid-session product retrieval and help staff prepare supplies in a predictable sequence before the injector enters the room.
Prefilled syringes can support efficient setup because staff do not need to transfer gel from another container. Even with this convenience, aseptic handling remains essential. Open sterile packaging only when the product is ready for professional use, and discard single-use components according to clinic policy and local requirements.
For staff education on why lidocaine is commonly used in filler formulations, see our article on lidocaine in dermal filler procedures. Clinics can also use broader filler education, such as types of dermal fillers, to support internal training discussions.
Comparable Products and Category Decisions
When stock planning across a clinic’s injectable menu, separate products by intended role: structural shaping, mid-depth volume, fine refinement, lip-focused work, and skin-quality support. This prevents one HA gel from being used as a universal substitute and helps align inventory with real procedure demand.
Clinics that perform lip-focused treatments may evaluate Revanesse Kiss with Lidocaine for protocols centered on lip contour and volume. For a different Revanesse HA presentation, Revanesse Pure with Lidocaine may be reviewed within brand-based procurement planning.
Why it matters: Matching filler characteristics to treatment goals improves inventory discipline and supports safer, more consistent clinical decision-making.
Authoritative Sources
Ready to align stock with scheduled contouring treatments? Sign in to view clinic pricing, confirm the 2 x 1.2 mL syringe format, and place an order for professional-use supply.
This content is for informational purposes only and is not a substitute for professional medical advice.
Frequently Asked Questions
What is Revanesse® Shape™ w/ Lidocaine used for in clinics?
It is a hyaluronic acid dermal filler used by trained healthcare professionals for contour-focused soft-tissue augmentation. Clinics may use it in protocols where structure, projection, and facial definition are treatment goals, subject to injector assessment and product instructions.
How many syringes are supplied in each box?
Each box contains two sterile, single-use prefilled syringes. Each syringe contains 1.2 mL of Revanesse® Shape™ w/ Lidocaine.
Does Revanesse® Shape™ contain lidocaine?
Yes. The supplied formulation includes lidocaine 0.3% along with hyaluronic acid 25 mg/mL. Lidocaine is included to support injection comfort during professional administration.
How should clinics document this filler on receipt?
Receiving staff should record the product name, lot number, expiry date, carton condition, and delivery location according to clinic policy. Any damaged packaging or unclear labeling should be quarantined before clinical use.
How long does Revanesse® Shape™ last?
Duration can vary by injection area, placement technique, patient anatomy, metabolism, and treatment plan. Clinics should rely on manufacturer materials, injector experience, and follow-up assessment rather than promising a fixed result timeline.
Is Revanesse® Shape™ better than Juvederm?
No single filler is best for every case. Clinics typically compare HA fillers by rheology, labeled use, handling, treatment area, patient anatomy, and injector preference. Product selection should be made by a qualified professional.
Specifications
- Main Ingredient: Hyaluronic Acid (25Mg/Ml) And Lidocaine (0.3%)
- Manufacturer: Prollenium Medical Technologies Inc.
- Drug Class: Dermal Filler
- Generic Name: Hyaluronic Acid
- Package Contents: 1.2 mL x 2 Pre-Filled Syringes
- Storage Requirements: Room Temperature (2℃~25℃)
- Main Usage: Volume Filler
About the Brand
Revanesse
Here to help
Questions about ordering, delivery or products? You can email our team here or call now at 1-800-630-9757 and be connected with your dedicated Account Manager
Related Products
You save (%)
Juvéderm® SKINVIVE
You save (%)
You save (%)
You save (%)
Related Articles
Hyaluronidase in Aesthetic Practice: Safety and Workflow
Hyaluronidase is an enzyme that breaks down hyaluronic acid, a water-binding molecule found in skin,…
Jawline Filler in Aesthetic Care: Safety and Workflow
Jawline filler is a nonsurgical dermal filler approach used to refine lower-face contour, support the…
Dermal Fillers Before and After: Assessing Results
Dermal fillers before and after review should show whether an injectable treatment produced a visible,…
Elasticity of the Skin: Assessment and Treatment Planning
Elasticity of the skin is the skin’s ability to stretch, resist deformation, and return toward…
How Long Does Mirena Last? Duration, Labeling, and Workflow
Mirena is labeled to prevent pregnancy for up to 8 years, but its labeled duration…
Is Evenity a Bisphosphonate? Drug Class and Care Context
No. If you are asking is evenity a bisphosphonate, the short answer is no. Evenity…
What Causes Double Chin? Clinical Drivers and Red Flags
The main causes double chin presentations reflect are usually submental fat, inherited facial anatomy, chin…
Skyla Vs Kyleena: Differences That Matter in IUD Selection
In a Skyla vs Kyleena comparison, the main operational difference is duration on the label:…

